Insulin Combo Reduces After-Meal Sugar Spikes in Type 1 Diabetics
In the midst of a legal litigation with Eli Lilly, Adocia has released Phase 1…
06/09/2018 - 2 minutes
Diabetes
Novo Nordisk Buys British ‘Smart’ Insulin Diabetes Biotech in deal worth €702M
Novo Nordisk acquired the UK biotech Ziylo, which develops glucose-responsive insulin treatments for diabetes that…
17/08/2018 - 2 minutes
Swedish Biotech Partners With Novo Nordisk to Advance Stem Cell Therapies for Diabetes
BioLamina has partnered with Novo Nordisk to develop stem cell therapies for diabetes and other…
16/05/2018 - 2 minutes
French Double-Hormone Diabetes Treatment to be Tested in Humans for the First Time
Adocia, a French biotech, will initiate a Phase I clinical study to test a diabetes…
16/04/2018 - 2 minutes
Graphene Skin Patch Measures Blood Sugar Without a Needle
Researchers in the UK have developed a skin patch that measures blood sugar levels without the…
12/04/2018 - 2 minutes
Cheese-Producing Bacteria Could Help Reverse Type 1 Diabetes
ActoBio Therapeutics has received permission from the FDA to start a clinical trial for a…
03/04/2018 - 2 minutes
This Swedish Discovery Could Change the Way We Treat Diabetes
Swedish researchers have found that insulin-producing cells alone are not enough to fine-tune blood sugar…
15/03/2018 - 3 minutes
French Biotech Takes its Oral Diabetes Drug to Phase III
Update (13/03/2018): Poxel has started two more Phase III trials in Japan testing its drug…
13/03/2018 - 3 minutes
French Biotech Targets Gut Microbiome to Treat Diabetes
Valbiotis has shown that its treatment restores diversity in a population of gut microorganisms imbalanced…
08/03/2018 - 3 minutes
Novo Nordisk Gets Close to Launching the First Oral GLP-1 Drug for Diabetes
Novo Nordisk has positive Phase III trial results for its oral version of semaglutide, a…
23/02/2018 - 3 minutes
This Mobile Diabetes Management System Can Reduce Hypoglycemia by 39%
The wireless system for diabetes management developed by Cellnovo can significantly reduce life-threatening events of…
15/02/2018 - 2 minutes
Watch Out Eli Lilly: Novo’s Diabetes Drug Ozempic Gets European Approval
Update (13/02/2018): The European Commission has given Novo Nordisk a market authorization for Ozempic (semaglutide), bringing…
13/02/2018 - 2 minutes
